Neuro-Oncology Reviews

Volume 27 Number 22
10 August 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 22, 10 August

Alomari O, Eyvazova H, Güney B, Al Juhmani R, Odabasi H, Al-Rawabdeh L, Mokresh ME, Erginoglu U, Keles A, Baskaya MK.
Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives.
Cancers (Basel). 2025 Aug 1;17(15):2550. doi: 10.3390/cancers17152550. PMID: 40805247. Review. ˍ

Hartanto RA, Malueka RG, Tamba DA, Lukito PP, Silvano F, Sutarni S.
The role of miRNA-10b and miRNA-21 in radioresistance and temozolomide resistance of high-grade glioma patients: a systematic review.
Neurosurg Focus. 2025 Aug 1;59(2):E2. doi: 10.3171/2025.5.FOCUS25304. PMID: 40749245. Review. ˍ

Liu J, He Z, An Z, Li S, Liu L, Liu Y.
Global research status, hotspots and prospects of ferroptosis in glioma: a scientometric analysis.
Front Cell Neurosci. 2025 Aug 1;19:1614710. doi: 10.3389/fncel.2025.1614710. PMID: 40822852. Bibliometric analysis. ˍ

Madour J, Bessette J, Gu JZ, Thayer EL, Elinzano H, Sax AJ.
Glioblastoma: Epidemiology and Imaging-Based Review.
R I Med J (2013). 2025 Aug 1;108(8):50-56. PMID: 40720688. Review. ˍ

Mortezaei A, Al-Saidi N, Taghlabi KM, Hajikarimloo B, Dib C, Hussein A, Abdelsalam A, Nemer P, Shepard MJ, Sheehan JP, Faraji AH.
Laser interstitial thermal therapy for high-grade glioma: a systematic review, meta-analysis, and meta-regression.
Neurosurg Focus. 2025 Aug 1;59(2):E10. doi: 10.3171/2025.5.FOCUS25316. PMID: 40749231. Review; Meta-analysis. ˍ

Shukla PD, Nguyen MP, Lee AT, Chang EF, Young JS.
Management of glioma-associated epilepsy in the molecular era: a review of the literature and an institutional experience.
Neurosurg Focus. 2025 Aug 1;59(2):E11. doi: 10.3171/2025.5.FOCUS25334. PMID: 40749243. Review. ˍ

Lohmann P, Schäfer L, Krause S, Altunay B, Willuweit A, Werner JM, Galldiks N, Langen KJ, Mottaghy FM, Lütje S.
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic review.
Neurooncol Adv. 2025 Aug 4;7(1):vdaf176. doi: 10.1093/noajnl/vdaf176. PMID: 41019666. Review. ˍ

Eksteen C, Riedemann J, Johnson H, Engelbrecht AM.
Literature review: CAR T-cell therapy as a promising immunotherapeutic approach for medulloblastoma.
Rev Neurol (Paris). 2025 Aug 5:S0035-3787(25)00555-7. doi: 10.1016/j.neurol.2025.07.005. PMID: 40764212. Review. ˍ

Huang H, Gao Y, Wu L, Song Z.
MRI Features for predicting brain invasion in meningiomas: A Systematic Review and Meta-Analysis.
World Neurosurg. 2025 Aug 5:124336. doi: 10.1016/j.wneu.2025.124336. PMID: 40754241. Review; Meta-analysis. ˍ

McLean H, Drill M, Sequeira R, Jayakrishnan PC, Jeffree RL, Hunn M, O'Brien TJ, Hamilton J, Monif M.
Harnessing the innate immune system for glioblastoma therapeutics.
J Neuroimmunol. 2025 Aug 5;407:578713. doi: 10.1016/j.jneuroim.2025.578713. PMID: 40795620. Review. ˍ

Standen L, Aslam A, Curran R, Derksen C, Yerrakalva D, McInnerney D, Brennan PM, Walter FM, Scott SE.
Can cognitive function tests discriminate between patients with glioma and healthy controls prior to treatment? A systematic review.
PLoS One. 2025 Aug 6;20(8):e0329663. doi: 10.1371/journal.pone.0329663. PMID: 40768488. Review. ˍ

Uwishema O, Shariff S, Wojtara M, Chakik JAE, Ghosh S, Obamiro K, Enam SA.
Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions.
Int J Emerg Med. 2025 Aug 6;18(1):144. doi: 10.1186/s12245-025-00921-4. PMID: 40770790. Review. ˍ

Wu Y, Liu Q, Xiang W, Fu P.
The immunosuppressive microenvironment modulated by glioma-associated mesenchymal stem cells: Current status and potential strategies.
Biochim Biophys Acta Rev Cancer. 2025 Aug 6;1880(5):189410. doi: 10.1016/j.bbcan.2025.189410. PMID: 40780462. Review˰ ˍ

Costantini S, Di Gennaro E, Fanelli G, Bagnara P, Argenziano C, Maccanico C, Paggi MG, Budillon A, Abbruzzese C.
Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy.
J Exp Clin Cancer Res. 2025 Aug 7;44(1):230. doi: 10.1186/s13046-025-03497-2. PMID: 40775789. Review. ˍ

Ghasemi Dehcheshmeh M, Eshaghian N, Mashayekhi S, Atayie F, Samii Kondrud F, Tavakoli L, Mohammadi MA, Asadi M, Askari G, Khodadadi A, Sadeghi O.
The Role of Dietary Patterns, Nutrient Intake, and Immune Modulation in Glioma Risk and Management.
Nutr Cancer. 2025 Aug 7:1-24. doi: 10.1080/01635581.2025.2539538. PMID: 40776399. Review˰ ˍ

Zarębska I, Blok M, Marjański M, Harat M.
The role of FET-PET in patient selection and response assessment for reirradiation in recurrent glioblastoma.
Front Oncol. 2025 Aug 7;15:1604448. doi: 10.3389/fonc.2025.1604448. PMID: 40852475. Review. ˍ

Huo X, Wang L, Ma J, Wu Z, Wang K.
Bibliometric analysis of publication trends in meningioma research (1992 - 2023).
Neurosurg Rev. 2025 Aug 8;48(1):595. doi: 10.1007/s10143-025-03739-z. PMID: 40779080. Bibliometric analysis˰ ˍ

Javid FA, Belancic A, Kwok MK, Lam YW.
Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022-2025).
Pharmacol Res Perspect. 2025 Aug 8;13(4):e70160. doi: 10.1002/prp2.70160. PMID: 40781861. Review. ˍ